TrialBritish journal of clinical pharmacology2009

Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN alpha-2a (40KD) (PEGASYS).

Brian Bressler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.